Similar articles

• Letrozole in breast cancer.

  Harris SR. Harris SR. N Engl J Med. 2004 Feb 12;350(7):727-30; author reply 727-30. N Engl J Med. 2004. PMID: 14971059 No abstract available.
• [Superiority of letrozole compared with tamoxifen as first line therapy of postmenopausal women with advanced breast cancer: results of a phase III study of the International Letrozole Breast Cancer Group].

  Illiger HJ. Illiger HJ. Strahlenther Onkol. 2002 Feb;178(2):111-3. Strahlenther Onkol. 2002. PMID: 11942036 Clinical Trial. German. No abstract available.
• Critics question price of success in halted clinical trial of aromatase inhibitor letrozole.

  Twombly R. Twombly R. J Natl Cancer Inst. 2003 Dec 3;95(23):1738-9. doi: 10.1093/jnci/95.23.1738. J Natl Cancer Inst. 2003. PMID: 14652229 No abstract available.
• The Letrozole Breast Cancer Trial: clinical implications and remaining questions.

  Chen WY, Manson JE. Chen WY, et al. Womens Health Issues. 2004 Jan-Feb;14(1):7-10. doi: 10.1016/j.whi.2003.12.006. Womens Health Issues. 2004. PMID: 15001182 Review. No abstract available.
• Steroidal aromatase inhibitors in elderly patients.

  Bajetta E, Zilembo N, Bichisao E, Pozzi P, Toffolatti L. Bajetta E, et al. Crit Rev Oncol Hematol. 2000 Feb;33(2):137-42. doi: 10.1016/s1040-8428(99)00062-1. Crit Rev Oncol Hematol. 2000. PMID: 10737375 Review.